









Markets
/
Stocks
/
nasdaq-asrt
/

Assertio Holdings Inc

ASRT

View Detailed Chart

0.713USD

-0.004-0.49%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

68.24MMarket Cap

LossP/E TTM



Assertio Holdings Inc

0.713

-0.004-0.49%

Overview Company Financials

Financials

Intraday

30m

Today

-0.49%

5 Days

-3.72%

1 Month

+9.11%

6 Months

-12.04%

Year to Date

-18.21%

1 Year

-44.77%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 4 analysts

BUY

Current Rating

2.800

Target Price

292.98%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

173

Total

Median

Average

Company name

Ratings

Analysts

Assertio Holdings Inc

ASRT

Biogen Inc

BIIB

Vertex Pharmaceuticals Inc

VRTX

Alnylam Pharmaceuticals Inc

ALNY

Amgen Inc

AMGN

Gilead Sciences Inc

GILD

...

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Neutral

Sell(6)

Neutral(3)

Buy(4)

Indicators

Sell(3)

Neutral(3)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.002

Neutral

RSI(14)

54.302

Neutral

STOCH(KDJ)(9,3,3)

32.602

Sell

ATR(14)

0.032

Low Volatility

CCI(14)

4.518

Neutral

Williams %R

56.604

Sell

TRIX(12,20)

0.423

Sell

StochRSI(14)

33.351

Buy

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

0.714

Sell

MA10

0.725

Sell

MA20

0.702

Buy

MA50

0.676

Buy

MA100

0.667

Buy

MA200

0.785

Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Assertio Holdings, Inc. is a commercial pharmaceutical company offering differentiated products to patients. The Company has built its commercial portfolio through acquisition or licensing of approved products. Its comprehensive commercial capabilities include marketing through both a sales force and a non-personal promotion model, market access through payor contracting and trade and distribution. The Company’s primary marketed products include ROLVEDONTM (eflapegrastim-xnst) injection for subcutaneous use, INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, Sympazan (clobazam) oral film, Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray, CAMBIA (diclofenac potassium for oral solution) and Zipsor (diclofenac potassium) Liquid filled capsules. INDOCIN (indomethacin) Suppositories and INDOCIN (indomethacin) Oral Suspension products are nonsteroidal anti-inflammatory drugs (NSAID).

Ticker SymbolASRT

CompanyAssertio Holdings Inc

CEOMr. Brendan P. O'Grady

Websitehttps://www.assertiotx.com/